Triferic Approval Status

Triferic (ferric pyrophosphate citrate) is an investigational iron-replacement drug for treating iron deficiency in chronic kidney disease patients receiving hemodialysis.

FDA Approval Status for Triferic

DateArticle
May 28, 2014Rockwell Medical Announces FDA Acceptance for Filing of Triferic New Drug Application
Mar 24, 2014Rockwell Medical Submits NDA for Triferic

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)